On the 24th, Osang Healthcare, a company specializing in in vitro diagnostics (IVD), announced that it will begin supplying a new personal blood glucose meter to the domestic market through Yuhan Corporation using an ODM model, thereby launching a full-scale attack on the domestic market.

This new product is a high-performance model manufactured based on Osang Healthcare's blood glucose meter development technology and know-how accumulated over 20 years.

 
According to the company, the model meets international quality standards (ISO 15197:2013) for accuracy, can measure both capillary blood from the fingertip and venous blood, and provides stable measurements across a wide hematocrit range of 10-70%. In addition, blood glucose levels are displayed in color for intuitive results, and usability has been enhanced with a large LCD screen and a newly applied test strip removal button, among other user-friendly features.
 

Full article : Osang Healthcare and Yuhan Corporation target the domestic personal blood glucose meter market